These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 426511)

  • 1. Pharmacology of cinoxacin in humans.
    Black HR; Israel KS; Wolen RL; Brier GL; Obermeyer BD; Ziege EA; Wolny JD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):165-70. PubMed ID: 426511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of probenecid on serum levels and urinary excretion of cinoxacin.
    Rodriguez N; Madsen PO; Welling PG
    Antimicrob Agents Chemother; 1979 Mar; 15(3):465-9. PubMed ID: 464575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.
    Burt RA; Morgan T; Payne JP; Bonner RM
    Br J Urol; 1977 Apr; 49(2):147-52. PubMed ID: 858034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
    Lumish RM; Norden CW
    Antimicrob Agents Chemother; 1975 Feb; 7(2):159-63. PubMed ID: 1094949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
    Maigaard S; Frimodt-Möller N; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1979 Sep; 16(3):411-6. PubMed ID: 507797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jul; 10(1):146-9. PubMed ID: 984747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcalorimetric investigation of the action of cinoxacin against Escherichia coli.
    Mårdh PA; Arhammer M; Colleen S; Andersson KE
    J Antimicrob Chemother; 1978 Jan; 4(1):73-8. PubMed ID: 342483
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
    Brogard JM; Comte F; Lavillaureix J
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):251-9. PubMed ID: 6653617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinoxacin: pharmacokinetics and the effect of probenecid.
    Israel KS; Black HR; Nelson RL; Brunson MK; Nash JF; Brier GL; Wolney JD
    J Clin Pharmacol; 1978 Oct; 18(10):491-9. PubMed ID: 711932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cinoxacin, ampicillin, and chloramphenicol against Shigella and nontyphoid Salmonella.
    Rubinstein E; Shainberg B
    Antimicrob Agents Chemother; 1977 Apr; 11(4):577-9. PubMed ID: 856008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cinoxacin in urinary tract infections.
    Panwalker AP; Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1976 Mar; 9(3):502-5. PubMed ID: 1259405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA; Collen S; Andersson KE
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of cinoxacin in vitro.
    Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1975 May; 7(5):688-92. PubMed ID: 1096811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of cinoxacin, an organic acid antibacterial.
    Kurtz S; Turck M
    Antimicrob Agents Chemother; 1975 Mar; 7(3):370-3. PubMed ID: 1137390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.
    Maigaard S; Frimodt-Möller N; Hoyme U; Madsen PO
    Invest Urol; 1979 Sep; 17(2):149-52. PubMed ID: 468515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinoxacin in urinary tract infections. Theoretical and practical considerations.
    Madsen PO; Frimodt-Møller N; Maigaard S; Nielsen OS; Rodriguez N; Welling PG
    Urology; 1981 May; 17(5):496-9. PubMed ID: 7233671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.
    Scavone JM; Gleckman RA; Fraser DG
    Pharmacotherapy; 1982; 2(5):266-72. PubMed ID: 6763208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound 64716, a new synthetic antibacterial agent.
    Wick WE; Preston DA; White WA; Gordee RS
    Antimicrob Agents Chemother; 1973 Oct; 4(4):415-20. PubMed ID: 4791302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinoxacin for treatment and prevention of recurrent urinary tract infection.
    Landes RR
    Urology; 1981 May; 17(5):505-10. PubMed ID: 7015670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.